Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review

Journal of Hospital Infection

Volumn 95, Issue 1, 2017, Pages 3-45

  French, C E ^a   Coope, C ^a,b   Conway, L ^a,b   Higgins, J P T ^a   McCulloch, J ^b   Okoli, G ^a   Patel, B C ^b   Oliver, I ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Acute settings; Carbapenem resistant Enterobacteriaceae; Carbapenemase producing Enterobacteriaceae; Infection control; Outbreak

Indexed keywords

CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CLEANING; ENTEROBACTERIACEAE INFECTION; EPIDEMIC; HAND WASHING; HUMAN; INFECTION CONTROL; PATIENT ISOLATION; PROTECTIVE CLOTHING; REVIEW; SCREENING; STAFF TRAINING; WASTE MANAGEMENT; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; HEALTH; INTENSIVE CARE; ISOLATION AND PURIFICATION; PROCEDURES; SECRETION (PROCESS);

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

BACTERIAL PROTEINS; BETA-LACTAMASES; CRITICAL CARE; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GLOBAL HEALTH; HUMANS; INFECTION CONTROL;

EID: 85007393575     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2016.10.006     Document Type: Review

References (138)

1. 1 Munoz-Price, L.S., Poirel, L., Bonomo, R.A., et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13 (2013), 785–796.
2. 2 Nordmann, P., Naas, T., Poirel, L., Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17 (2011), 1791–1798.
3. 3 Albiger, B., Glasner, C., Struelens, M.J., et al. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 20 (2015), 1–18.
4. 4 Public Health England, English surveillance programme for antimicrobial utilisation and resistance (ESPAUR). Report 2014., 2014, Public Health England, London.
5. 5 Falagas, M.E., Tansarli, G.S., Karageorgopoulos, D.E., et al. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 20 (2014), 1170–1175.
6. 6 Canton, R., Akova, M., Carmeli, Y., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18 (2012), 413–431.
7. 7 Savard, P., Perl, T.M., A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute care settings. Curr Opin Infect Dis 25 (2012), 371–377.
8. 8 Patel, G., Huprikar, S., Factor, S.H., et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29 (2008), 1099–1106.
9. 9 Borer, A., Saidel-Odes, L., Riesenberg, K., et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 30 (2009), 972–976.
10. 10 Gregory, C.J., Llata, E., Stine, N., et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 31 (2010), 476–484.
11. 11 MacDonald, C., Thomas, S., Thornhill, C., A study to identify risk factors for the acquisition of carbapenemase-producing Gram-negative organisms in a tertiary hospital serving a major international airport. Clin Microbiol Infect 17 (2011), S150–S151.
12. 12 Sanchez-Romero, I., Asensio, A., Oteo, J., et al. Nosocomial outbreak of VIM-1-producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 56 (2012), 420–427.
13. 13 Rossini, A., Di Santo, S.G., Libori, M.F., et al. Risk factors for carbapenemase-producing Enterobacteriaceae colonization of asymptomatic carriers on admission to an Italian rehabilitation hospital. J Hosp Infect 92 (2016), 78–81.
14. 14 Grundmann, H., Livermore, D.M., Giske, C.G., et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 15 (2010), 1–13.
15. 15 Kola, A., Piening, B., Pape, U.F., et al. An outbreak of carbapenem-resistant OXA-48-producing Klebsiella pneumonia associated to duodenoscopy. Antimicrob Resist Infect Control 4 (2015), 1–4.
16. 16 Naas, T., Cuzon, G., Babics, A., et al. Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase. J Antimicrob Chemother 65 (2010), 1305–1306.
17. 17 Alrabaa, S.F., Nguyen, P., Sanderson, R., et al. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control 41 (2013), 562–564.
18. 18 Carbonne, A., Thiolet, J.M., Fournier, S., et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill 15 (2010), 1–6.
19. 19 Birgand, G., Moore, L.S., Bourigault, C., et al. Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?. Clin Microbiol Infect, 22, 2016 162e1–162e9.
20. 20 Lutgring, J.D., Limbago, B.M., The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection. J Clin Microbiol 54 (2016), 529–534.
21. 21 Rossolini, G.M., Extensively drug-resistant carbapenemase-producing Enterobacteriaceae: an emerging challenge for clinicians and healthcare systems. J Intern Med 277 (2015), 528–531.
22. 22 Tangden, T., Giske, C.G., Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. J Intern Med 277 (2015), 501–512.
23. 23 European Centres for Disease Prevention and Control, Directory of guidance on prevention and control of carbapenem-resistant Enterobacteriaceae. 2015, ECDC, Stockholm Available at: http://ecdc.europa.eu/en/healthtopics/Healthcare-associated_infections/guidance-infection-prevention-control/Pages/guidance-prevention-control-infections-CRE.aspx#sthash.8wxv4gAU.dpuf [last accessed April 2015].
24. 24 Savard, P., Carroll, K.C., Wilson, L.E., et al. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos. Infect Control Hosp Epidemiol 34 (2013), 730–739.
25. 25 European Centre for Disease Prevention and Control, Systematic review of the effectiveness of infection control measures to prevent the transmission of carbapenemase-producing Enterobacteriaceae through cross-border transfer of patients. 2014, ECDC, Stockholm.
26. 26 Higgins, J.P.T., Green, S.M., Cochrane handbook for systematic reviews of interventions. Version 5.1.0, 2011, The Cochrane Collaboration, Oxford.
27. 27 Moher, D., Liberati, A., Tetzlaff, J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
28. 28 Centre for Reviews and Dissemination, Systematic reviews. CRD's guidance for undertaking reviews in health care. 2009, University of York, York.
29. 29 Wells, G.A., Shea, B., O'Connell, D., et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. 2014, Ottawa Hospital Research Institute, Ottawa Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [last accessed June 2015].
30. 30 Epstein, L., Hunter, J.C., Arwady, M.A., et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 312 (2014), 1447–1455.
31. 31 Espasa-Soley, M., Fernandez, I., Oteo, J., et al. A nosocomial outbreak of a carbapenem-resistant Klebsiella pneumoniae ST-663 producing OXA-48 and CTX-M-15 related to a duodenoscope contamination. Clin Microbiol Infect, 18, 2012, 531.
32. 32 Koo, V.S., O'Neill, P., Elves, A., Multidrug-resistant NDM-1 klebsiella outbreak and infection control in endoscopic urology. BJU Int 110 (2012), E922–E926.
33. 33 Sanderson, R., Braithwaite, L., Ball, L., et al. An outbreak of carbapenem-resistant Klebsiella pneumoniae infections associated with endoscopic retrograde cholangiopancreatography (ERCP) procedures at a hospital. Am J Infect Control, 38, 2010, E141.
34. 34 Dai, Y., Zhang, C., Ma, X., et al. Outbreak of carbapenemase-producing Klebsiella pneumoniae neurosurgical site infections associated with a contaminated shaving razor used for preoperative scalp shaving. Am J Infect Control 42 (2014), 805–806.
35. 35 Kotsanas, D., Wijesooriya, W.R.P.L.I., Korman, T.M., et al. “Down the drain”: carbapenem-resistant bacteria in intensive care unit patients and handwashing sinks. Med J Aust 198 (2013), 267–269.
36. 36 Leitner, E., Zarfel, G., Luxner, J., et al. Contaminated handwashing sinks as the source of a clonal outbreak of KPC-2-producing Klebsiella oxytoca on a hematology ward. Antimicrob Agents Chemother 59 (2014), 714–716.
37. 37 Vergara-Lopez, S., Dominguez, M.C., Conejo, M.C., et al. Wastewater drainage system as an occult reservoir in a protracted clonal outbreak due to metallo-beta-lactamase-producing Klebsiella oxytoca. Clin Microbiol Infect 19 (2013), E490–E498.
38. 38 Ben-David D, Tal I, Barssessat A, et al. An outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae associated with a damaged therapeutic mattress. 23rd European Congress of Clinical Microbiology and Infectious Diseases, 27–30 April 2013, Berlin, Germany.
39. 39 Ben-David, D., Maor, Y., Keller, N., et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31 (2010), 620–626.
40. 40 Borer, A., Eskira, S., Nativ, R., et al. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in southern Israel. Infect Control Hosp Epidemiol 32 (2011), 1158–1165.
41. 41 Chitnis, A.S., Caruthers, P.S., Rao, A.K., et al. Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions. Infect Control Hosp Epidemiol 33 (2012), 984–992.
42. 42 Ciobotaro, P., Oved, M., Nadir, E., et al. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 39 (2011), 671–677.
43. 43 Cohen, M.J., Block, C., Levin, P.D., et al. Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective. Infect Control Hosp Epidemiol 32 (2011), 673–678.
44. 44 Enfield, K.B., Huq, N.N., Gosseling, M.F., et al. Control of simultaneous outbreaks of carbapenemase-producing Enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promotedin the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae toolkit. Infect Control Hosp Epidemiol 35 (2014), 810–817.
45. 45 Munoz-Price, L.S., Hayden, M.K., Lolans, K., et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 31 (2010), 341–347.
46. 46 Patel, G., Bonomo, R.A., “Stormy waters ahead”: global emergence of carbapenemases. Front Microbiol 4 (2013), 1–17.
47. 47 Dortet, L., Poirel, L., Nordmann, P., Worldwide dissemination of the NDM-type carbapenemases in Gram-negative bacteria. BioMed Res Int 2014 (2014), 1–12.
48. 48 Keswani, R.N., Soper, N.J., Endoscopes and the “superbug” outbreak. JAMA Surg 150 (2015), 831–832.
49. 49 Muscarella, L.F., Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc 6 (2014), 457–474.
50. 50 Department of Health, UK five year antimicrobial resistance strategy 2013 to 2018. 2013, Department of Health, London, 1–43.
51. 51 Davey, P., Brown, E., Charani, E., et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev, 4, 2013, CD003543.
52. 52 Ventola, C.L., The antibiotic resistance crisis: part 2: management strategies and new agents. P T 40 (2015), 344–352.
53. 53 Munoz-Price, L.S., Quinn, J.P., Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis 26 (2013), 378–387.
54. 54 Centers for Disease Control and Prevention, Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) – November 2015 update – CRE toolkit. 2015, CDC, Atlanta, GA, 1–24.
55. 55 Public Health England, Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. 2013, PHE, London, 1–37.
56. 56 Tacconelli, E., Cataldo, M.A., Dancer, S.J., et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20:Suppl. 1 (2014), 1–55.
57. 57 Wilson, A.P.R., Livermore, D.M., Otter, J.A., et al. Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. J Hosp Infect 92:Suppl. (2016), S1–S44.
58. 58 Wendt, C., Schutt, S., Dalpke, A.H., et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 29 (2010), 563–570.
59. 59 Larson, E.L., Cimiotti, J.P., Haas, J., et al. Gram-negative bacilli associated with catheter-associated and non-catheter-associated bloodstream infections and hand carriage by healthcare workers in neonatal intensive care units. Pediatr Crit Care Med 6 (2005), 457–461.
60. 60 Gammon, J., Morgan-Samuel, H., Gould, D., A review of the evidence for suboptimal compliance of healthcare practitioners to standard/universal infection control precautions. J Clin Nurs 17 (2008), 157–167.
61. 61 Public Health England, UK standards for microbiological investigations: detection of bacteria with carbapenem-hydrolysing β-lactamases (carbapenemases). 2014, PHE, London, 1–41.
62. 62 Stone, S.P., Cooper, B.S., Kibbler, C.C., et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 7 (2007), 282–288.
63. 63 Novak, A., Goic-Barisic, I., Andrasevic, A.T., et al. Monoclonal outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in intensive care unit, University Hospital Centre Split, Croatia. Microbial Drug Resist 20 (2014), 399–403.
64. 64 Kanerva M, Skogberg K, Pahkamäki A, et al. First outbreak of carbapenamase-producing Klebsiella pneumoniae strain (ST512) in a Finnish long-term acute care hospital, June 2013. 24th European Congress of Clinical Microbiology and Infectious Diseases, 10–13 May 2014, Barcelona, Spain.
65. 65 Cuzon, G., Ouanich, J., Gondret, R., et al. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother 55 (2011), 2420–2423.
66. 66 Kassis-Chikhani, N., Saliba, F., Carbonne, A., et al. Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003–2004. Euro Surveill 15 (2010), 1–7.
67. 67 Levast, M., Poirel, L., Carrer, A., et al. Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France. J Antimicrob Chemother 66 (2011), 944–945.
68. 68 Semin-Pelletier, B., Cazet, L., Bourigault, C., et al. Challenges of controlling a large outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in a French university hospital. J Hosp Infect 89 (2015), 248–253.
69. 69 Ducomble, T., Faucheux, S., Helbig, U., et al. Large hospital outbreak of KPC-2-producing Klebsiella pneumoniae: investigating mortality and the impact of screening for KPC-2 with polymerase chain reaction. J Hosp Infect 89 (2015), 179–185.
70. 70 Lubbert, C., Faucheux, S., Becker-Rux, D., et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents 42 (2013), 565–570.
71. 71 Steinmann, J., Kaase, M., Gatermann, S., et al. Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill 16 (2011), 1–6.
72. 72 Douka, E., Perivolioti, E., Kraniotaki, E., et al. Emergence of a pandrug-resistant VIM-1-producing Providencia stuartii clonal strain causing an outbreak in a Greek intensive care unit. Int J Antimicrob Agents 45 (2015), 533–536.
73. 73 Karampatakis, T., Athanasoula, E., Sianou, E., et al. Outbreak of carbapenemase-producing Klebsiella pneumoniae and Enterobacter cloacae strains in a Greek university hospital. Clin Microbiol Infect, 18, 2012, 411.
74. 74 Papadomichelakis, E., Pontikis, K., Matthaiopoulou, F., et al. A large outbreak of KPC-producing Klebsiella pneumoniae and efforts to control it. Intensive Care Med, 35, 2009, S197.
75. 75 Souli, M., Galani, I., Antoniadou, A., et al. An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 50 (2010), 364–373.
76. 76 Voulgari, E., Gartzonika, C., Vrioni, G., et al. The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece. J Antimicrob Chemother 69 (2014), 2091–2097.
77. 77 Voulgari, E., Zarkotou, O., Ranellou, K., et al. Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother 68 (2013), 84–88.
78. 78 Maltezou, H.C., Giakkoupi, P., Maragos, A., et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 58 (2009), 213–219.
79. 79 Morris, D., Boyle, F., Morris, C., et al. Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland. J Antimicrob Chemother 67 (2012), 2367–2372.
80. 80 Ronayne, A., O'Brien, D., Wrenn, C., et al. An outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in an Irish tertiary referral centre in 2011. Clin Microbiol Infect, 18, 2012, 286.
81. 81 Schaffer, K., Ronayne, A., O'Brien, D., et al. An outbreak of OXA-48 carbapenemase producing Klebsiella pneumoniae in an Irish tertiary referral centre in 2011. Int J Med Microbiol, 302, 2012, 139.
82. 82 Wrenn, C., O'Brien, D., Keating, D., et al. Investigation of the first outbreak of OXA-48-producing Klebsiella pneumoniae in Ireland. J Hosp Infect 87 (2014), 41–46.
83. 83 Agodi, A., Voulgari, E., Barchitta, M., et al. Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy. J Clin Microbiol 49 (2011), 3986–3989.
84. 84 Gaibani, P., Ambretti, S., Farruggia, P., et al. Outbreak of Citrobacter freundii carrying Vim-1 in an Italian hospital, identified during the carbapenemase screening actions, June 2012. Int J Infect Dis 17 (2013), e714–e717.
85. 85 Gaibani, P., Colombo, R., Arghittu, M., et al. Successful containment and infection control of a carbapenem-resistant Klebsiella pneumoniae outbreak in an Italian hospital. New Microbiol 37 (2014), 87–90.
86. 86 Giuffre, M., Bonura, C., Geraci, D.M., et al. Successful control of an outbreak of colonization by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae sequence type 258 in a neonatal intensive care unit, Italy. J Hosp Infect 85 (2013), 233–236.
87. 87 Mammina, C., Bonura, C., Di Bernardo, F., et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill, 17, 2012, 20120816.
88. 88 Mammina, C., Palma, D.M., Bonura, C., et al. Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae carbapenemase 3 in an intensive care unit in Italy. J Clin Microbiol 48 (2010), 1506–1507.
89. 89 Mezzatesta, M.L., Gona, F., Caio, C., et al. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Clin Microbiol Infect 17 (2011), 1444–1447.
90. 90 Nouvenne, A., Ticinesi, A., Cerundolo, N., et al. Carbapenemase-producing Klebsiella pneumoniae (KPC) infection outbreak in Italy: report of an experience with elderly frail patients. Eur J Intern Med, 24, 2013, e197.
91. 91 Anesi A, Asticcioli S, Baroni D, et al. Containment of an outbreak of KPC-producing Klebsiella pneumoniae in a geriatric ward. 25th European Congress of Clinical Microbiology and Infectious Diseases, 25–28 April 2015, Copenhagen, Denmark.
92. 92 Rossi, M., Migliorino, G., Motta, E., et al. Evaluation of control measurement procedures in the prevention of carbapenemase-2 (KPC-2)-producing Klebsiella pneumoniae nosocomial transmission. Clin Microbiol Infect, 17, 2011, S371.
93. 93 Mena, A., Plasencia, V., Garcia, L., et al. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44 (2006), 2831–2837.
94. 94 Nieto-Gonzalez, M., Del Diego-Salas, J., Hernandez-Rodriguez, J.V., et al. Nosocomial outbreak due to clonal ESBL klebsiella strain at a intensive care unit. Intensive Care Med, 36, 2010, S256.
95. 95 Olea Jimenez, V., Mora Ordonez, J.M., Curiel Balsera, E., We are all necessary against the outbreak. Intensive Care Med, 39, 2013, S515.
96. 96 Pano-Pardo, J.R., Ruiz-Carrascoso, G., Navarro-San Francisco, C., et al. Infections caused by oxa-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak. J Antimicrob Chemother 68 (2013), 89–96.
97. 97 Pitart, C., Sole, M., Roca, I., et al. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother 55 (2011), 4398–4401.
98. 98 Robustillo Rodela, A., Diaz-Agero Perez, C., Sanchez Sagrado, T., et al. Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures. Euro Surveill 17 (2012), 1–6.
99. 99 Madueno A, Lecuona M, Delgado T, et al. Emergence and outbreak of OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Canary Island (Spain): epidemiology and control measures. Infection Prevention Society Conference 2014, 29 May 2014, Glasgow, UK.
100. 100 Lemmenmeier, E., Kohler, P., Bruderer, T., et al. First documented outbreak of KPC-2-producing Klebsiella pneumoniae in Switzerland: infection control measures and clinical management. Infection 42 (2014), 529–534.
101. 101 Dautzenberg, M.J., Ossewaarde, J.M., de Kraker, M.E., et al. Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011. Euro Surveill 19 (2014), 1–12.
102. 102 Meessen, N., Wiersinga, J., Van Der Zwaluw, K., et al. First outbreak of carbapenemase-producing Klebsiella pneumoniae in a tuberculosis care facility in the Netherlands. Clin Microbiol Infect, 16, 2010, S361.
103. 103 Weterings V, Weterings E, Verkade E, et al. Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae (KPC-Kp) in the Netherlands, with inter-institutional spread. 24th European Congress of Clinical Microbiology and Infectious Diseases, 10–13 May 2014, Barcelona, Spain.
104. 104 Poirel, L., Yilmaz, M., Istanbullu, A., et al. Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother 58 (2014), 2929–2933.
105. 105 Thomas, C.P., Moore, L.S.P., Elamin, N., et al. Early (2008–2010) hospital outbreak of Klebsiella pneumoniae producing OXA-48 carbapenemase in the UK. Int J Antimicrob Agents 42 (2013), 531–536.
106. 106 Davis S, Prtak L, Parsons H. Managing an outbreak of carbapenem resistant organisms: infection control from a patient perspective in a long-stay rehabilitation environment. Federation of Infection Societies 2013 Annual Conference, 11–13 November 2013, Birmingham, UK.
107. 107 Verma, A., Philpotthoward, J., Baker, A., et al. Outbreak of BLA VIM-4 carbapenemase producing Enterobacteriaceae in a pediatric liver transplant centre: a new threat to our antibiotics armamentarium. Liver Transpl, 19, 2013, S128.
108. 108 Borgia, S., Lastovetska, O., Richardson, D., et al. Outbreak of carbapenem-resistant Enterobacteriaceae containing bla NDM-1, Ontario, Canada. Clin Infect Dis 55 (2012), e109–e117.
109. 109 Lowe, C.F., Kus, J.V., Salt, N., et al. Nosocomial transmission of New Delhi metallo-b-lactamase-1-producing Klebsiella pneumoniae in Toronto, Canada. Infect Control Hosp Epidemiol 34 (2013), 49–55.
110. 110 Chandran AU, Wolfe AL, Manca S, et al. Investigation of a multiple multidrug-resistant Gram-negative bacilli outbreak in a Canadian hospital (or Help!! We have CRE!!). IDWeek 2012, 17–21 October 2012, San Diego, CA, USA.
111. 111 Endimiani, A., DePasquale, J.M., Forero, S., et al. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 64 (2009), 1102–1110.
112. 112 Epson, E.E., Pisney, L.M., Wendt, J.M., et al. Carbapenem-resistant Klebsiella pneumoniae producing New Delhi metallo-beta-lactamase at an acute care hospital, Colorado, 2012. Infect Control Hosp Epidemiol 35 (2014), 390–397.
113. 113 Greene, L.R., Investigation of a cluster of Klebsiella pneumoniae carbapenemase-producing organisms on a long-term care ventilator unit. American Journal of Infection Control Conference: 38th Annual Educational Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control, 39, 2011, E118.
114. 114 Marchaim, D., Chopra, T., Pogue, J.M., et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother 55 (2011), 593–599.
115. 115 Munoz-Price, L.S., De La Cuesta, C., Adams, S., et al. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 31 (2010), 1074–1077.
116. 116 Nadkarni, A.S., Schliep, T., Khan, L., et al. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Am J Infect Control 37 (2009), 121–126.
117. 117 Palmore, T.N., Henderson, D.K., Managing transmission of carbapenem-resistant Enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis 57 (2013), 1593–1599.
118. 118 Rosenberger, L.H., Hranjec, T., Politano, A.D., et al. Effective cohorting and “superisolation” in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms. Surg Infect 12 (2011), 345–350.
119. 119 Snitkin, E.S., Zelazny, A.M., Thomas, P.J., et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4 (2012), 1–18.
120. 120 Abdalla, M., Monaster, D., Allen, B., et al. CRE: the role of infection preventionists in identifying epidemiological links in outbreak situations. Am J Infect Control 1 (2014), S160–S161.
121. 121 Preas, M.A., Conway, L., Hebden, J., et al. Investigation of a multi-drug resistant Klebsiella pneumoniae outbreak in a cardiac surgery intensive care unit (CSICU). American Journal of Infection Control Conference: 38th Annual Educational Conference and International Meeting of the Association for Professionals in Infection Control and Epidemiology, Inc. Am J Infect Control 39 (2011), E117–E118.
122. 122 Adler, A., Solter, E., Masarwa, S., et al. Epidemiological and microbiological characteristics of an outbreak caused by OXA-48-producing Enterobacteriaceae in a neonatal intensive care unit in Jerusalem, Israel. J Clin Microbiol 51 (2013), 2926–2930.
123. 123 Nasser, D.Y., Karmi, O., Alawaneh, J., et al. The control of a carbapenem resistant Enterobacteriaceae outbreak at Augusta Victoria Hospital, East Jerusalem, Palestine; applying CDC recommendations while addressing local challenges. Am J Infect Control 1 (2014), S152–S153.
124. 124 Oved, M., Ciobotaro, P., Efrimi, Y., et al. Management and containment of patients colonized/infected with carbapenem resistant Klebsiella pneumoniae CRKP in an acute care hospital in an endemic country. Am J Infect Control 37 (2009), E80–E81.
125. 125 Geffen, Y., Finkelstein, R., Oren, I., et al. Changing epidemiology of carbapenem-resistant Enterobacteriaceae carriage during an outbreak of carbapenem-resistant Klebsiella pneumoniae. J Hosp Infect 76 (2010), 355–356.
126. 126 Balkhy, H.H., El-Saed, A., Al Johani, S.M., et al. The epidemiology of the first described carbapenem-resistant Klebsiella pneumoniae outbreak in a tertiary care hospital in Saudi Arabia: how far do we go?. Eur J Clin Microbiol Infect Dis 31 (2012), 1901–1909.
127. 127 Pang, F., Jia, X.Q., Wang, B., et al. Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases. Pathol Biol (Paris) 62 (2014), 152–155.
128. 128 Wenjun S, Xinxin L. Outbreak of Klebsiella pneumonia producing KPC-2 carbapenemase in an intensive care unit in China. 23th European Congress of Clinical Microbiology and Infectious Diseases, 27–30 April 2013, Berlin, Germany.
129. 129 Fukigai, S., Alba, J., Kimura, S., et al. Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. Int J Antimicrob Agents 29 (2007), 306–310.
130. 130 Chae J, Choe W, Kim M. First outbreak of OXA-232 producing Klebsiella pneumoniae in a Korean secondary care hospital. 24th European Congress of Clinical Microbiology and Infectious Diseases, 10–13 May 2014, Barcelona, Spain.
131. 131 Carrilho, C., Pascual Garcia, J.C., Belei, R.A., et al. Outbreak of carbapenem-resistant enterobacteria in a Brazilian university hospital. Clin Microbiol Infect 17 (2011), S775–S776.
132. 132 Pereira, G.H., Garcia, D.O., Mostardeiro, M., et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae: two-year epidemiologic follow-up in a tertiary hospital. Mem Inst Oswaldo Cruz 108 (2013), 113–115.
133. 133 Zavascki, A.P., Carvalhaes, C.G., da Silva, G.L., et al. Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit. Infect Control Hosp Epidemiol 33 (2012), 627–630.
134. 134 Escobar Perez, J.A., Olarte Escobar, N.M., Castro-Cardozo, B., et al. Outbreak of NDM-1-producing Klebsiella pneumoniae in a neonatal unit in Colombia. Antimicrob Agents Chemother 57 (2013), 1957–1960.
135. 135 Ingold, A., Echeverria, N., Acevedo, A., et al. KPC producing Klebsiella pneumoniae in Uruguay: first two clinical cases and isolates’ characteristics report. Clin Microbiol Infect, 18, 2012, 531.
136. 136 Marquez, C., Ingold, A., Echeverria, N., et al. Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: infection control and molecular characterization. New Microb New Infect 2 (2014), 58–63.
137. 137 Herbert, S., Halvorsen, D.S., Leong, T., et al. Large outbreak of infection and colonization with Gram-negative pathogens carrying the metallo-beta-lactamase gene blaIMP-4 at a 320-bed tertiary hospital in Australia. Infect Control Hosp Epidemiol 28 (2007), 98–101.
138. 138 de Jager, P., Chirwa, T., Naidoo, S., et al. Nosocomial outbreak of New Delhi metallo-beta-lactamase-1-producing Gram-negative bacteria in South Africa: a case–control study. PLoS One, 10, 2015, e0123337.